Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Precancerous Conditions × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Breast Carcinoma In Situ 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1

Interventions

Whole-Body Irradiation 4 Sulindac 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 fludarabine phosphate 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Cetuximab 3 Tacrolimus 2 Sirolimus 2 Selenium 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Mycophenolic Acid 2 Melphalan 2 Gene Expression Profiling 2 Etoposide 2 Darbepoetin alfa 2 Cyclosporine 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 Biopsy 2 Aspirin 2 Aminolevulinic Acid 2 Albumin-Bound Paclitaxel 2 vandetanib 1 polyphenon E 1 perillyl alcohol 1 peginterferon alfa-2b 1 human papillomavirus vaccine, L1 type 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡